2. Academic Validation
  3. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets

  • Nat Rev Drug Discov. 2003 Apr;2(4):278-88. doi: 10.1038/nrd1065.
Donald M Coen 1,  Priscilla A Schaffer
Affiliations

Affiliation

  • 1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachussets 02115, USA. don_coen@hms.harvard.edu
PMID: 12669027 DOI: 10.1038/nrd1065
Abstract

In the absence of effective vaccines to control herpesvirus infections, nucleosidic Antiviral drugs have been the mainstay of clinical treatment since their development in the late 1970s. However, given the drawbacks of these drugs, including the increasing emergence of drug-resistant clinical isolates, new strategies for treating herpesvirus infections are warranted. A range of promising new drugs with novel molecular targets has been developed, but will they cure latent infections?

Figures
Products